Want to see IN:PFIZER full AI Analyst Report?
PFIZER Stock Chart & Stats
₹4743.95
₹24.30(0.52%)
At close: 4:00 PM EDT
₹4743.95
₹24.30(0.52%)
Day’s Range― - ―
52-Week Range₹3,590.00 - ₹5,329.05
Previous CloseN/A
Volume14.93K
Average Volume (3M)8.73K
Market Cap
₹168.67B
Enterprise Value₹185.51B
Total Cash (Recent Filing)₹30.88B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)22.9
Beta0.69
Next Earnings
Nov 03, 2026EPS Estimate
53.23Next Dividend Ex-DateN/A
Dividend Yield2.03%
Share Statistics
EPS (TTM)160.69
Shares Outstanding45,747,730
10 Day Avg. Volume19,035
30 Day Avg. Volume8,731
Financial Highlights & Ratios
PEG Ratio-5.08
Price to Book (P/B)5.14
Price to Sales (P/S)8.57
P/FCF Ratio19.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)182.4
Revenue Forecast (FY)₹27.34B
Bulls Say, Bears Say
Bulls Say
Very Low LeverageA very low and improving debt-to-equity profile limits balance-sheet strain and preserves financial flexibility. That resilience can support continued research and development, operating needs, and capital returns while reducing the company’s exposure to financing pressure over the next several quarters.
Strong ProfitabilityConsistently high profitability indicates that Pfizer Limited converts revenue into substantial earnings across its pharmaceutical operations. Durable margins provide internal funding for commercial activities and innovation, while also offering a stronger buffer against changes in product mix or market conditions.
Improved Cash GenerationThe recent improvement in operating cash flow and close alignment between free cash flow and earnings point to stronger earnings quality. If sustained, this conversion can support reinvestment, distributions, and financial flexibility without relying as heavily on external funding.
Bears Say
Uneven Revenue TrendThe uneven revenue pattern indicates that top-line momentum has not been consistently durable across recent years. Although the latest rebound is encouraging, prior declines make future growth more dependent on sustaining product demand and maintaining commercial execution across operating markets.
Gross-Margin PressureA notable gross-margin decline can reduce the earnings contribution from each unit of revenue and may weaken the sustainability of profitability if it persists. The company remained profitable, but this change warrants monitoring because margin recovery is important for preserving operating leverage.
Cash-Flow VolatilityEarlier periods of weaker cash conversion show that reported earnings have not translated consistently into operating cash flow. Even with the recent improvement, this variability can complicate funding and capital-allocation planning if cash generation again diverges from accounting profits.
PFIZER LIMITED News
PFIZER FAQ
What was PFIZER LIMITED’s price range in the past 12 months?
PFIZER LIMITED lowest stock price was ₹3590.00 and its highest was ₹5329.05 in the past 12 months.
What is PFIZER LIMITED’s market cap?
PFIZER LIMITED’s market cap is ₹168.67B.
When is PFIZER LIMITED’s upcoming earnings report date?
PFIZER LIMITED’s upcoming earnings report date is Nov 03, 2026 which is in 2 days.
How were PFIZER LIMITED’s earnings last quarter?
PFIZER LIMITED released its earnings results on Jul 28, 2026. The company reported ₹44.7 earnings per share for the quarter, missing the consensus estimate of ₹45.2 by -₹0.5.
Is PFIZER LIMITED overvalued?
According to Wall Street analysts PFIZER LIMITED’s price is currently Overvalued.
Does PFIZER LIMITED pay dividends?
PFIZER LIMITED pays a Notavailable dividend of ₹75 which represents an annual dividend yield of 2.03%. See more information on PFIZER LIMITED dividends here
What is PFIZER LIMITED’s EPS estimate?
PFIZER LIMITED’s EPS estimate is 53.23.
How many shares outstanding does PFIZER LIMITED have?
PFIZER LIMITED has 45,747,730 shares outstanding.
What happened to PFIZER LIMITED’s price movement after its last earnings report?
PFIZER LIMITED reported an EPS of ₹44.7 in its last earnings report, missing expectations of ₹45.2. Following the earnings report the stock price went up 0.329%.
Which hedge fund is a major shareholder of PFIZER LIMITED?
Currently, no hedge funds are holding shares in IN:PFIZER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PFIZER LIMITED
Pfizer Limited operates as a pharmaceutical company, engaged in the development, promotion, sale, and international export of medicinal products. Its diverse product range addresses numerous therapeutic needs, such as those related to the neuro/central nervous system, hormonal balance, cardiovascular health, hemophilia, infectious diseases, gynecology, pain relief, orthopedic conditions, oncology, urology, parasitic infections, gastrointestinal disorders, vaccinations, respiratory ailments, and nutritional supplements. The company markets its offerings predominantly under various brand names through an extensive network of independent distributors. Established in 1950, its corporate headquarters are situated in Mumbai, India.
Technical Analysis
Abbott India Limited
―
Cipla Ltd
―
Gland Pharma Ltd.
―
GlaxoSmithKline Pharmaceuticals Limited
―
Sanofi India Limited
―